Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Silvernest is a leading AgeTech company that operates a comprehensive home-sharing platform specifically designed for the aging population and the longevity economy. The company's digital marketplace utilizes a proprietary matching algorithm to pair homeowners aged 50 and older with compatible housemates, facilitating co-living arrangements that support aging in place. By addressing critical social determinants of health such as social isolation and financial instability, Silvernest provides a non-pharmacological intervention to improve the well-being of seniors. The platform offers a suite of tools including background checks, automated rent collection, and legal lease templates to ensure secure and sustainable housing solutions. In February 2024, Silvernest was acquired by Parentis Health, a move that integrated its housing platform into a broader continuum of healthcare and senior support services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Silvernest.